Expression of the uPA system has been shown to be an important prognostic marker in a variety of cancers including breast cancer [15], lung cancer [16], and colorectal cancer [17], with the combination of uPA and PAI-1 expression recommended to be incorporated into routine clinical care of node negative breast cancer [18]. Here, PLAU is linked to breast carcinoma.